PTSD & Cannabis
Track symptom response across products. Build predictions for which chemical profiles correlate with reduced PTSD symptom severity.
PTSD (Post-Traumatic Stress Disorder) is one of the conditions most actively studied in the context of medical cannabis. Veterans and trauma survivors are among the growing populations exploring cannabis alongside conventional PTSD treatments.
TOQidex provides structured symptom tracking across 10 PTSD-specific dimensions, tied to the actual chemistry of each product. This creates a personal dataset that can reveal patterns invisible to subjective memory alone.
10 Symptoms, Tied to Chemistry
Cannabis & PTSD
Cannabis and PTSD is an active area of clinical research, particularly among veteran populations. Results so far are mixed and more studies are needed. Here is what some of the current literature explores:
- Fear extinction research: Some researchers are studying how endocannabinoid signaling may relate to fear extinction processes, which are believed to be disrupted in PTSD. This is an early area of investigation.
- Nightmare reports: Some PTSD patients have reported reduced nightmare frequency with certain cannabis products. This is based on self-reported data, not controlled clinical trials.
- Hyperarousal research: Researchers are investigating whether cannabinoids may modulate aspects of the stress response system. Evidence is preliminary.
Important: TOQidex does not make medical claims about cannabis and PTSD. PTSD is a serious condition requiring professional care. The platform helps you track your self-reported responses, not replace treatment. Always work with a healthcare professional.
Studied for potential effects on fear extinction and nightmare reduction.
Studied for anxiolytic properties relevant to PTSD hyperarousal.
Potential sleep support for PTSD-related insomnia.
Calming properties may support hyperarousal symptom management.
Relaxing terpene that may support sleep quality.
Anti-inflammatory CB2 interaction may support overall wellbeing.
Frequently Asked Questions
Is cannabis approved for PTSD?
Cannabis access for PTSD varies by jurisdiction. TOQidex is a tracking tool, not a treatment recommendation.
How does tracking help with PTSD?
Structured tracking helps you identify which products and chemical profiles correlate with reduced symptom severity, providing data for conversations with your care team.
From the Blog
Why Strain Names Are Unreliable (And What to Track Instead)
A study of 89,923 cannabis samples found that indica, sativa, and hybrid labels showed "no obvious segregation" against actual chemistry. Only 4 of 30 strains maintained consistent profiles across dispensaries. Here is what the research says.
Cannabinoids and Terpenes: The Chemistry That Drives Your Cannabis Experience
THC percentage is one data point. Your cannabis experience is shaped by at least 8 major cannabinoids and 9 dominant terpenes working together. Here is what the current research says about each compound.
Why TOQidex Tracks These 13 Medical Conditions
Over 6 million Americans hold medical cannabis cards. The conditions they manage are not random. Here is the data behind the 13 conditions TOQidex supports, why we chose them, and what the research says about patient-reported outcomes.
Other Conditions We Track
Start Tracking Your Experience
Join TOQidex to track how different products affect your symptoms.
Sign Up FreeTOQidex tracks user-reported symptom response. It does not diagnose, treat, cure, or prevent any condition. All outputs reflect probability based on your personal logged data.